🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.
Salud Compra fuertePrecio actual
59,53 USD
Máx. histórico
2.925,00
12010 días
Split 1:10 del 17/11/2011
Caída desde máximo
-97,96%
Rango 52 semanas
37,06 – 95,49
Variación hoy
-0,07%
Cierre anterior
59,57
Rango de hoy
59,25 – 60,89
Volumen hoy
1.327.132
Peor caída histórica
-99,96%
16/12/1993 → 16/12/2016
Aún sin recuperar
Volatilidad anualizada ⓘ
231,88%
- Nombre completo
- Arrowhead Pharmaceuticals, Inc.
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 711
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 107,71 USD (puede no estar actualizado)
- Primera cotización
- 16/12/1993
- Precio actualizado
- hace 13 horas
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.
| Fecha | Ratio |
|---|---|
| 17/11/2011 | 1:10 |
| 15/01/2004 | 1:65 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 19/12/2023 | 28,38 | 30,09 | 28,36 | 30,00 | +7,37% | 6,10% | 1.636.800 |
| 18/12/2023 | 28,59 | 28,93 | 27,34 | 27,94 | -2,14% | 5,56% | 870.400 |
| 15/12/2023 | 28,64 | 29,48 | 27,73 | 28,55 | +0,00% | 6,11% | 3.659.200 |
| 14/12/2023 | 27,53 | 29,28 | 27,53 | 28,55 | +6,13% | 6,36% | 1.685.100 |
| 13/12/2023 | 24,63 | 26,93 | 24,54 | 26,90 | +8,95% | 9,70% | 1.672.900 |
| 12/12/2023 | 23,79 | 24,79 | 23,06 | 24,69 | +3,44% | 7,26% | 941.800 |
| 11/12/2023 | 24,37 | 24,50 | 23,70 | 23,87 | -0,33% | 3,28% | 1.109.700 |
| 08/12/2023 | 24,44 | 25,10 | 23,92 | 23,95 | -2,36% | 4,83% | 913.000 |
| 07/12/2023 | 23,79 | 24,93 | 23,51 | 24,53 | +3,11% | 5,97% | 1.363.900 |
| 06/12/2023 | 23,70 | 23,93 | 23,36 | 23,79 | +1,54% | 2,41% | 1.475.700 |
| 05/12/2023 | 24,56 | 24,73 | 23,40 | 23,43 | -6,02% | 5,39% | 1.634.400 |
| 04/12/2023 | 23,33 | 24,93 | 23,20 | 24,93 | +7,60% | 7,42% | 2.796.200 |
| 01/12/2023 | 21,55 | 23,24 | 20,67 | 23,17 | +9,29% | 11,93% | 4.222.200 |
| 30/11/2023 | 28,11 | 28,32 | 21,16 | 21,20 | -26,85% | 25,47% | 5.980.400 |
| 29/11/2023 | 29,48 | 29,48 | 28,80 | 28,98 | +0,21% | 2,32% | 874.800 |
| 28/11/2023 | 28,39 | 29,10 | 27,92 | 28,92 | +0,73% | 4,16% | 705.000 |
| 27/11/2023 | 28,88 | 29,14 | 28,32 | 28,71 | -1,41% | 2,84% | 863.700 |
| 24/11/2023 | 28,98 | 29,70 | 28,77 | 29,12 | +0,55% | 3,21% | 306.100 |
| 22/11/2023 | 28,88 | 29,33 | 28,39 | 28,96 | +2,08% | 3,25% | 635.100 |
| 21/11/2023 | 28,53 | 28,75 | 28,00 | 28,37 | -1,83% | 2,63% | 713.400 |
| 20/11/2023 | 28,06 | 29,16 | 27,85 | 28,90 | +2,99% | 4,65% | 875.200 |
| 17/11/2023 | 26,29 | 28,29 | 26,19 | 28,06 | +7,67% | 7,99% | 1.302.600 |
| 16/11/2023 | 26,57 | 27,21 | 25,64 | 26,06 | -3,52% | 5,91% | 1.022.200 |
| 15/11/2023 | 27,46 | 29,07 | 26,97 | 27,01 | -1,42% | 7,65% | 1.157.400 |
| 14/11/2023 | 27,35 | 27,49 | 26,10 | 27,40 | +5,51% | 5,08% | 1.664.700 |
| 13/11/2023 | 26,57 | 26,68 | 25,11 | 25,97 | -3,67% | 5,91% | 1.201.400 |
| 10/11/2023 | 27,03 | 27,23 | 26,24 | 26,96 | +0,82% | 3,66% | 916.800 |
| 09/11/2023 | 27,37 | 27,37 | 26,59 | 26,74 | -1,29% | 2,87% | 924.300 |
| 08/11/2023 | 27,27 | 28,06 | 27,02 | 27,09 | -1,53% | 3,81% | 842.200 |
| 07/11/2023 | 26,90 | 27,59 | 26,56 | 27,51 | +2,15% | 3,81% | 775.400 |